Screener
Vor Biopharma VOR Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
| (in thousands, except share and per share amounts) | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ deficit(1): | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 0 shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 800,000,000 and 400,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; 54,185,582 and 38,720,196 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 19 | 18 |
| Additional paid-in capital | 1,222,823 | 988,604 |
| Accumulated other comprehensive (loss) income | (706) | 41 |
| Accumulated deficit | (1,372,560) | (1,152,975) |
| Total stockholders’ deficit | (150,424) | (164,312) |
| Total liabilities and stockholders’ deficit | $506,746 | $464,126 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Vor Biopharma's total liabilities & equity?
- Vor Biopharma (VOR) reported total liabilities & equity of $506.75M in Q1 2026.
- How has Vor Biopharma's total liabilities & equity changed year-over-year?
- Vor Biopharma's total liabilities & equity increased by 363.6% year-over-year, from $109.31M to $506.75M.
- What is the long-term trend for Vor Biopharma's total liabilities & equity?
- Over 5 years (2020 to 2025), Vor Biopharma's total liabilities & equity has grown at a 43.6% compound annual growth rate (CAGR), from $75.91M to $464.13M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Vor Biopharma's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude